Abbott Laboratories (ABT)
87.18
-0.36
(-0.41%)
USD |
NYSE |
May 05, 16:00
87.21
+0.03
(+0.03%)
After-Hours: 20:00
Abbott Laboratories Cash from Investing (Quarterly) : -20.32B for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -591.00M |
| Intuitive Surgical, Inc. | -914.50M |
| Insulet Corp. | -152.80M |
| ResMed, Inc. | -58.03M |
| Baxter International, Inc. | -133.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.315B |
| Cash from Financing (Quarterly) | 17.31B |
| Free Cash Flow | 7.378B |
| Free Cash Flow Per Share (Quarterly) | 0.5243 |
| Free Cash Flow to Equity (Quarterly) | -19.00B |
| Free Cash Flow to Firm (Quarterly) | 993.30M |
| Free Cash Flow Yield | 4.84% |